BlackRock Institutional Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$461M	Buy	12,724,714 +12,577,643	+8,552%	+$502M	0.07%	287
2016 Q3	$6.77M	Sell	147,071 -38,450	-21%	-$2.01M	﹤0.01%	2567
2016 Q2	$9.32M	Buy	185,521 +9,000	+5%	+$479K	﹤0.01%	2329
2016 Q1	$9.45M	Buy	176,521 +3,190	+2%	+$187K	﹤0.01%	2292
2015 Q4	$11.4M	Buy	173,331 +31,494	+22%	+$1.95M	﹤0.01%	2240
2015 Q3	$8.01M	Sell	141,837 -90,148	-39%	-$5.85M	﹤0.01%	2436
2015 Q2	$13.7M	Sell	231,985 -238,721	-51%	-$14.7M	﹤0.01%	2182
2015 Q1	$29.3M	Buy	470,706 +267,610	+132%	+$15.6M	﹤0.01%	1686
2014 Q4	$11.7M	Buy	203,096 +64,987	+47%	+$3.62M	﹤0.01%	2275
2014 Q3	$7.42M	Buy	138,109 +31,596	+30%	+$1.67M	﹤0.01%	2490
2014 Q2	$5.58M	Buy	106,513 +6,701	+7%	+$343K	﹤0.01%	2736
2014 Q1	$5.27M	Buy	99,812 +38,512	+63%	+$1.78M	﹤0.01%	2760
2013 Q4	$2.46M	Sell	61,300 -33,941	-36%	-$1.34M	﹤0.01%	3075
2013 Q3	$3.6M	Sell	95,241 -211,882	-69%	-$8.27M	﹤0.01%	2874
2013 Q2	$12M	Buy	+307,123	New	+$12M	﹤0.01%	2190